Neuren Pharmaceuticals Ltd Cash Flow Quality Index
Neuren Pharmaceuticals Ltd cash flow quality index. Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow Quality Index of 8.54x as of June 2025. Operating cash flow of AU$128.31 Million exceeds net income of AU$15.03 Million, indicating high earnings quality where cash backs reported profits. See Neuren Pharmaceuticals Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Neuren Pharmaceuticals Ltd (2009–2024)
Cash flow quality index of Neuren Pharmaceuticals Ltd from 2009 to 2024. Historical Cash Flow Quality Index for Neuren Pharmaceuticals Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Neuren Pharmaceuticals Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Neuren Pharmaceuticals Ltd Cash Flow Quality Index by Year (2009–2024)
Neuren Pharmaceuticals Ltd cash flow quality index by year from 2009 to 2024. Year-by-year earnings quality comparison for Neuren Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Neuren Pharmaceuticals Ltd cash flow conversion.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.08x | AU$-11.27 Million | AU$142.04 Million | ▼ -106.7% |
| 2023 | 1.18x | AU$184.93 Million | AU$157.08 Million | ▼ -94.0% |
| 2022 | 19.56x | AU$3.60 Million | AU$184.00K | ▲ +838.0% |
| 2018 | 2.09x | AU$6.41 Million | AU$3.07 Million | ▲ +222.7% |
| 2017 | -1.70x | AU$-5.59 Million | AU$3.29 Million | ▲ +86.8% |
| 2009 | -12.93x | AU$-1.29 Million | AU$99.56K | — |